Actavis, Mylan Can Use Expert's Word In Heart Drug MDL

Law360, New York (October 21, 2011, 9:13 PM EDT) -- A West Virginia federal judge on Friday rejected plaintiffs' bid to block the use of certain expert testimony in a multidistrict litigation against Actavis Inc. and Mylan Inc. over a heart drug recall, finding defense attorneys had not violated any professional conduct rule.

The plaintiffs — various classes of Digitek users — contended that Dr. David Bliesner's deposition, taken Sept. 19 for another Digitek case pending in Oklahoma state court, was inappropriate for the multidistrict litigation because it was done without the plaintiffs' knowledge or the...
To view the full article, register now.